These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37867221)

  • 1. The relationship between alterations in plasma metabolites and treatment responses in antipsychotic-naïve female patients with schizophrenia.
    Wang X; Xie J; Ma H; Li G; Li M; Li S; Sun X; Zhao Y; Sun W; Yang S; Li J
    World J Biol Psychiatry; 2024 Feb; 25(2):106-115. PubMed ID: 37867221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study.
    Liu Y; Song X; Liu X; Pu J; Gui S; Xu S; Tian L; Zhong X; Zhao L; Wang H; Liu L; Xu G; Xie P
    Psychiatry Clin Neurosci; 2021 Apr; 75(4):138-144. PubMed ID: 33421228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study.
    Guan X; Xu J; Xiu M; Li X; Liu H; Wu F
    CNS Neurosci Ther; 2022 Oct; 28(10):1539-1546. PubMed ID: 35769008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Plasma Biomarkers in Drug-Naïve Schizophrenia Using Targeted Metabolomics.
    Su Q; Bi F; Yang S; Yan H; Sun X; Wang J; Qiu Y; Li M; Li S; Li J
    Psychiatry Investig; 2023 Sep; 20(9):818-825. PubMed ID: 37794663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metabolic profiling using small molecular water-soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre-post-treatment design.
    Cao B; Jin M; Brietzke E; McIntyre RS; Wang D; Rosenblat JD; Ragguett RM; Zhang C; Sun X; Rong C; Wang J
    Psychiatry Clin Neurosci; 2019 Mar; 73(3):100-108. PubMed ID: 30156046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.
    Kelemen O; Kiss I; Benedek G; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():13-9. PubMed ID: 23954737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential plasma biomarker panels identification for the diagnosis of first-episode schizophrenia and monitoring antipsychotic monotherapy with the use of metabolomics analyses.
    Song M; Liu Y; Zhou J; Shi H; Su X; Shao M; Yang Y; Wang X; Zhao J; Guo D; Liu Q; Zhang L; Zhang Y; Lv L; Li W
    Psychiatry Res; 2023 Mar; 321():115070. PubMed ID: 36706560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
    Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment.
    Kriisa K; Leppik L; Balõtšev R; Ottas A; Soomets U; Koido K; Volke V; Innos J; Haring L; Vasar E; Zilmer M
    J Proteome Res; 2017 Oct; 16(10):3558-3566. PubMed ID: 28786289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma metabonomics study of first-Episode schizophrenia treated with olanzapine in female patients.
    Qiao Y; Zhang L; He S; Wen H; Yu YM; Cao CH; Li HF
    Neurosci Lett; 2016 Mar; 617():270-6. PubMed ID: 26924724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of eicosanoids and related mediators in patients with schizophrenia.
    Wang D; Sun X; Yan J; Ren B; Cao B; Lu Q; Liu Y; Zeng J; Huang N; Xie Q; Gu H; Wang J
    J Psychiatr Res; 2018 Jul; 102():168-178. PubMed ID: 29674269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic Connections between Schizophrenia, Antipsychotic Drugs and Metabolic Syndrome: A Variety of Players.
    Molina JD; Avila S; Rubio G; López-Muñoz F
    Curr Pharm Des; 2021; 27(39):4049-4061. PubMed ID: 34348619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis.
    Bojesen KB; Broberg BV; Fagerlund B; Jessen K; Thomas MB; Sigvard A; Tangmose K; Nielsen MØ; Andersen GS; Larsson HBW; Edden RAE; Rostrup E; Glenthøj BY
    Biol Psychiatry; 2021 Feb; 89(3):278-287. PubMed ID: 32928500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease.
    Parksepp M; Leppik L; Koch K; Uppin K; Kangro R; Haring L; Vasar E; Zilmer M
    Sci Rep; 2020 Aug; 10(1):13983. PubMed ID: 32814830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma γ-aminobutyrate/glutamate ratio and responses to risperidone antipsychotic treatment in schizophrenia.
    Cai HL; Zhu RH; Li HD; Zhang XH; Hu L; Yang W; Ye HS
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1273-8. PubMed ID: 20637820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bl-1020, a new γ-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomized, double-blind, controlled, efficacy and safety study.
    Geffen Y; Keefe R; Rabinowitz J; Anand R; Davidson M
    J Clin Psychiatry; 2012 Sep; 73(9):e1168-74. PubMed ID: 23059159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
    Li M; Chen Z; Deng W; He Z; Wang Q; Jiang L; Ma X; Wang Y; Chua SE; Cheung C; McAlonan GM; Sham PC; Collier DA; Gong Q; Li T
    Psychol Med; 2012 Jul; 42(7):1475-83. PubMed ID: 22030695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-naïve patients with schizophrenia.
    Liu JH; Chen N; Guo YH; Guan XN; Wang J; Wang D; Xiu MH
    J Psychiatr Res; 2021 Aug; 140():409-415. PubMed ID: 34144444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia.
    Yan H; Li G; Zhang X; Zhang C; Li M; Qiu Y; Sun W; Dong Y; Li S; Li J
    BMC Psychiatry; 2024 May; 24(1):355. PubMed ID: 38741058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia.
    Wang D; Cheng SL; Fei Q; Gu H; Raftery D; Cao B; Sun X; Yan J; Zhang C; Wang J
    Psychiatry Res; 2019 Feb; 272():18-29. PubMed ID: 30579177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.